Overview
Megakaryocytes are specialized hematopoietic cells residing primarily in bone marrow, constituting <0.1% of nucleated marrow cells. They undergo endomitosis—a unique cell cycle variant resulting in polyploidy (typically 16N-32N DNA content)—without cytokinesis. This genomic amplification supports massive cytoplasmic expansion required for platelet biogenesis. The cells were first described in 1906 by James Homer Wright, who linked them to platelet production through histological observations. Modern studies classify megakaryocytes into developmental stages (MK-I to MK-IV) based on size, nuclear lobulation, and cytoplasmic granularity. Their differentiation from hematopoietic stem cells is driven primarily by thrombopoietin (TPO) signaling via the c-MPL receptor, with additional modulation by cytokines like IL-3 and IL-6.
Key Features
A defining feature is the development of proplatelet extensions—long cytoplasmic projections that traverse bone marrow sinusoids and release platelets into circulation. Each megakaryocyte can generate 1,000-3,000 platelets through this process. Ultrastructurally, they contain abundant α-granules (storing fibrinogen, von Willebrand factor) and dense granules (ADP, calcium), which later equip platelets for hemostasis. Biomarkers include surface expression of CD41 (integrin αIIb), CD61 (integrin β3), and CD42 (GP1b-IX-V complex). Flow cytometry panels often combine these with CD34 (progenitor stage) and CD45 (hematopoietic lineage). Recent single-cell RNA sequencing has further refined transcriptional signatures across maturation stages, revealing subpopulations with distinct platelet-producing capacities.
Application Areas
In clinical practice, megakaryocyte quantity and morphology in bone marrow biopsies help diagnose thrombocytopenias (e.g., immune thrombocytopenia vs. aplastic anemia) and myelodysplastic syndromes. Ex vivo expansion of megakaryocytes from cord blood or induced pluripotent stem cells (iPSCs) is being developed for platelet transfusion alternatives, addressing shortages and pathogen risks in donor-derived products. Pharmaceutical research utilizes megakaryocyte cultures to study thrombopoiesis-stimulating drugs (e.g., romiplostim, eltrombopag) and model genetic disorders like Bernard-Soulier syndrome. Emerging applications include engineered platelets for targeted drug delivery and 3D bioprinted marrow niches to study leukemia microenvironment interactions.
Precautions
Working with primary megakaryocytes requires careful handling due to their fragility—mechanical stress during isolation can trigger premature platelet release. Culture systems typically use collagen-coated surfaces with TPO-supplemented media, maintaining 37°C with 5% CO2. Hypoxia conditions (1-5% O2) better mimic marrow physiology and improve differentiation efficiency. Pathological overproduction occurs in essential thrombocythemia and primary myelofibrosis, often driven by JAK2 or CALR mutations. Conversely, chemotherapy or radiation can deplete megakaryocyte pools, necessitating platelet transfusions. Researchers should validate disease models using both genomic profiling and functional assays like proplatelet formation analysis.
B2B Procurement Guide
For research institutions, key suppliers include STEMCELL Technologies (human/mouse progenitor kits), Lonza (primary cells), and ATCC (cell lines like Meg-01). Bulk procurement for therapeutic development requires GMP-compliant systems, such as PluriSTEM’s bioreactor platforms. Pricing varies significantly: research-grade mouse megakaryocytes cost approximately $200-500 per million cells, while clinical-grade human equivalents exceed $10,000 per batch. Selection criteria should prioritize batch consistency (flow cytometry QC data), species compatibility, and scalability. For drug screening applications, consider pre-differentiated cells to reduce protocol variability. Emerging options include gene-edited iPSC-derived megakaryocytes with reporter constructs for high-throughput assays.
Related Manufacturers
- 主营：ELISA试剂盒、PCR试剂盒、生化试剂盒、细胞、蛋白、抗体、检测试剂盒
- 主营：酶cγ链、α2巨球、素d合成、纤连蛋白、抗组蛋白、肌醇抗体、蛋白样环、敏感蛋白、牛骨钙素、蛋白重链、金属肽酶、乳球蛋白、钩端螺旋、蛋白激酶、高血糖素、钙调蛋白、小鼠α1抗、ELISA试剂盒、pcr检测试剂、生化检测试剂
- 主营：膀胱癌细胞、人胚肾细胞、前列腺癌细胞
- 主营：elisa试剂盒、荧光试剂盒、抗体、生物试剂、化学试剂、培养基、标准品、比色法试剂盒
- 主营：ATCC细胞系、原代细胞、原代永生化
- 主营：ELISA试剂盒、PCR试剂盒、生化试剂盒、1细胞、科研试剂
- 主营：抑制物、糖蛋白、试剂盒、淋巴细胞、释放因子、人色氨酰、炎性蛋白、刺激因子、生长因子、武装因子、钙黏蛋白、成孔蛋白、趋化因子、人促睡眠肽、免疫球蛋白、节苷脂抗体、人精氨酸酶、二聚化蛋白、人β葡糖苷酶、人β内酰胺酶、肝炎病毒抗体、活化黏附因子、凋亡抑制因子、人潜伏膜蛋白、人二氢嘧啶酶
- 主营：试剂盒、马血浆、脂质体、干细胞、白细胞、狗血浆、羊血浆、抗凝鹅、酶标板、羊血清、移液器、培养液、无酚红、胶原酶、分子量、鼠血浆、缓冲液、猪血清、培养基、肝素钠、食蟹猴、牛血浆、鸭血浆、血制品、氯化钠
- 主营：脂蛋白、蛋白酶、肉毒碱、瘤细胞、细胞株、癌细胞、信号素、测试盒、切蛋白、样蛋白、羧化酶、子宫肌、质激素、羧肽酶、坏血酸、合成酶、视网膜、同源物、骨钙素、羧激酶、白介素、加压素、纤溶酶、骨桥素、干扰素
- 主营：氮气发生器、氮吹仪、冷冻干燥机、高温喷雾干燥机、赶酸器、恒温摇床、恒温解冻仪、智能集菌仪、种子培养箱、固相萃取仪、水浴融浆机、干式氮吹仪、汞灯反应器、全封闭氮吹仪、圆形水浴氮吹仪